21 completed, 7 unknown, 6 recruiting, 2 active not recruiting. 23 Not applicable, 4 Phase 2, 2 Phase 4, 1 Phase 1, 1 Phase 3.
Follow Pars Plana Vitrectomy: new trials by email Literature Review of Pars Plana Vitrectomy trials Research Report on Pars Plana Vitrectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative Vitreoretinopathy Enoxaparin Sodium, Pars Plana Vitrectomy - Rhegmatogenous Retinal Detachment With Grade C Proliferative Vitreoretinopathy | Not applicable | Active not recruiting | Lahore General Hospital | 60 | 2026-05-01 | 2026-08-26 |
| Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population Pars plana vitrectomy - Retinal Detachment Rhegmatogenous, Vitrectomy | Not applicable | Completed | Wardah | 78 | 2025-04-15 | 2026-03-31 |
| Intravitreal Topotecan for Prevention or Treatment of Proliferative Vitreoretinopathy in Retinal Detachment Intravitreal topotecan, Retinal detachment surgery - Retinal Detachment Rhegmatogenous, Proliferative Vitreoretinopathy | Phase 2 | Not yet recruiting | Unity Health Toronto | 394 | 2025-03-01 | 2025-03-06 |
| Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes Pars plana vitrectomy - Idiopathic Macular Hole, Macular Hole | Not applicable | Enrolling by invitation | The Filatov Institute of Eye Diseases and Tissue Therapy | 100 | 2025-02-01 | 2025-04-17 |
| Progression Suppression and Retinal Regression in VEGF-resistant AMD Pars plana vitrectomy - Neovascular Age-related Macular Degeneration (AMD) | Not applicable | Recruiting | PharmaBio Corporation | 10 | 2024-09-12 | 2026-09-18 |
| Predictors of Vitrectomy Outcomes in Myopic Foveoschisis pars plana vitrectomy - Myopic Traction Maculopathy | Not applicable | Recruiting | Singapore National Eye Centre | 30 | 2024-06-10 | 2026-08-19 |
| Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy Subtreshold micropulse laser therapy, Pars plana vitrectomy - Epiretinal Membrane, Macular Oedema | Not applicable | Enrolling by invitation | Pomeranian Medical University Szczecin | 100 | 2024-05-09 | 2025-09-10 |
| Caffeine and Cataract After Pars Plana Vitrectomy Pars plana vitrectomy - Cataract | Not applicable | Unknown | Vienna Institute for Research in Ocular Surgery | 74 | 2024-04-01 | 2024-04-12 |
| Compare PPV With and Without Silicone Oil in Managing Postoperative Endophthalmitis Pars plana Vitrectomy, Silicone Oil - Endophthalmitis Following Cataract Surgery | Not applicable | Completed | Benha University | 40 | 2024-01-20 | 2025-05-25 |
| Phacovitrectomy Versus Pars Plana Vitrectomy Alone for Post-Intravitreal Injection Endophthalmitis Phacovitrectomy, Pars plana vitrectomy - Endophthalmitis, Endophthalmitis Postoperative | Not applicable | Completed | Benha University | 40 | 2024-01-15 | 2026-07-21 |
| REtinal Detachment Outcomes Study Pars plana vitrectomy, Pars plana vitrectomy with scleral buckle, Sulfur hexafluoride gas tamponade - Retinal Detachment | Not applicable | Recruiting | CHU de Quebec-Universite Laval | 560 | 2023-09-26 | 2023-11-18 |
| Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique Pars plana vitrectomy, IOL explantation, Scleral IOL fixation Yamane Technique - Lens Luxation, IOL Subluxation | Not applicable | Recruiting | Medical University of Vienna | 100 | 2023-09-19 | 2023-10-26 |
| Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA) Pars plana vitrectomy - Myopic Chorioretinal Atrophy | Not applicable | Active not recruiting | PharmaBio Corporation | 10 | 2023-02-17 | 2026-09-29 |
| 3D Visualization System for Vitreoretinal Diseases in Highly Myopic Eyes pars plana vitrectomy, NGENUITY® 3D Visualization System (Alcon, TX, USA) - Patients With Highly Myopic Eyes | Not applicable | Completed | National Taiwan University Hospital | 40 | 2022-10-07 | 2024-06-17 |
| Air Versus Gas Tamponade in Primary Retinal Detachment Pars plana vitrectomy - Retinal Detachment, Proliferative Vitreoretinopathy | Not applicable | Unknown | Benha University | 40 | 2022-09-26 | 2022-09-30 |
| Dropless Pars Plana Vitrectomy Study Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or Polymyxin/Trimethoprim if patient is allergic to moxifloxacin - Rhegmatogenous Retinal Detachment | Phase 4 | Completed | Massachusetts Eye and Ear Infirmary | 168 | 2022-07-25 | 2026-09-18 |
| Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study pars plana vitrectomy - Macular Holes | Not applicable | Unknown | Fayoum University | 28 | 2021-12-01 | 2024-01-31 |
| Intravitreal Infliximab for Proliferative Vitreoretinopathy Intravitreal infliximab, Pars plana vitrectomy - Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy | Phase 2 | Completed | Cairo University | 66 | 2021-11-26 | 2024-01-19 |
| Quantification of Silicone Oil Emulsification After Pars Plana Vitrectomy pars plana vitrectomy - PArs Plana Vitrectomy, Retinal Detachment | Unknown | Ospedale Policlinico San Martino | 20 | 2021-06-01 | 2021-10-27 | |
| Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER). Pars plana vitrectomy, Intravitreal 2 mg aflibercept will be injected at baseline then monthly for two further doses, then 2-monthly until month 12, subretinal injection of recombinant TPA (Alteplase) up to a maximum of 25 micrograms in 0.2 mls - Eye Diseases, Macular Degeneration, Wet | Phase 3 | Recruiting | King's College Hospital NHS Trust | 210 | 2021-04-16 | 2026-09-11 |
Showing 20 of 40. Sign in to see all of them.
Retinal Detachment (11) · Epiretinal Membrane (5) · Vitreoretinopathy, Proliferative (5) · Retinal Diseases (4) · Retinal Perforations (4) · Vitreous Hemorrhage (4) · Diabetic Retinopathy (3) · Cataract (2) · Endophthalmitis (2) · Macular Edema (2) · Aniseikonia (1) · Eye Diseases (1) · Inflammation (1) · Lens Subluxation (1) · Myopia, Degenerative (1)
Benha University (3) · National Taiwan University Hospital (2) · Ospedale Policlinico San Martino (2) · PharmaBio Corporation (2) · Unity Health Toronto (2) · University of Sao Paulo (2) · Aier School of Ophthalmology, Central South University (1) · Allen C. Ho, MD (1) · Allergan (1) · Barnes Retina Institute (1) · Bo Jia (1) · Bursa Retina Eye Hospital (1) · CHU de Quebec-Universite Laval (1) · Cairo University (1) · Chongqing Medical University (1)
Egypt (6) · United States (5) · China (4) · Brazil (3) · Canada (3) · Austria (2) · Italy (2) · Japan (2) · Pakistan (2) · Poland (2) · Taiwan (2) · Germany (1) · Indonesia (1) · Ireland (1) · Netherlands (1)
Hitoshi Kusano, M.D. (2) · Tommaso Rossi (2) · Abdul Sami Memon, FCPS (1) · Ahmad Fauzan (1) · Ahmed A Abdel-Kader, MD, PhD (1) · Ahmed A Abdelshafy, MD (1) · Ahmed M Abdelbaki, MD, PhD (1) · Ahmed M Younes, MD, MSc (1) · Ahmed Shawkat, MD (1) · Ali Dirani, MD MSc MPH (1) · Allen C Ho, MD (1) · Andrew Tsai, MD (1) · Ayman G Elnahry, MD, PhD (1)
PMID 18851731, PMID 19208678, PMID 19584650, PMID 21278146, PMID 24246446, PMID 27429390, PMID 28498374, PMID 32411388, PMID 35101110, PMID 37217137, PMID 38124155, PMID 39716323, PMID 39966901, PMID 40229856